跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,994 条关于
“GENTI-122”
全部
3,994
临床试验
2,029
药物
1,444
机构
10
资讯
511
9个月前
Regulatory T Cell Therapies Advance Through Clinical Development with Enhanced Monitoring Technologies
2年前
Can B Corp Acquires Cannabis Patents Valued at $122 Million Through Court Assignment
去年
Nanjing Leads Biolabs Soars 122% on Hong Kong Debut Following HK$1.1 Billion IPO
4个月前
CREATE Medicines Raises $122 Million to Advance In Vivo CAR-T Therapies for Cancer and Autoimmune Diseases
8个月前
EnteroBiotix's EBX-102-02 Shows Promise as First-in-Class Oral Microbiome Therapy for Irritable Bowel Syndrome
2年前
LB Pharmaceuticals Advances Schizophrenia Treatment with LB-102
去年
EnteroBiotix Completes Phase 2 Trial Recruitment of EBX-102-02 for Irritable Bowel Syndrome
去年
Biosimilar SB17 Demonstrates Sustained Efficacy and Safety After Switching from Ustekinumab in Psoriasis Patients
去年
EnteroBiotix Completes Enrollment in Phase 2 Trial of EBX-102 for Irritable Bowel Syndrome
去年
EnteroBiotix Completes Phase 2 Trial Recruitment of EBX-102-02 for Irritable Bowel Syndrome
第 1 页,共 52 页
上一页
下一页